Annual Integrated Report | Takeda Pharmaceuticals

Children Running

Annual Integrated Report

Daughter and father

2023 Annual Integrated Report

Every day, we work to ensure long-term sustainable growth, innovation and resilience. Our Annual Integrated Report outlines the progress we made in FY2022 to deliver on our purpose of better health for people and a brighter future for the world.
Open the full reportArrow bottom

Sustainability Framework

We developed our corporate philosophy imperatives: Patient, People and Planet, which identify where Takeda must invest to deliver on our purpose, informed by an ESG materiality assessment of strategically important nonfinancial issues to our company and stakeholders. In FY2022, we evolved these imperatives to create a simplified sustainability framework and sustainability focus areas.

Sustainability Framework
Find the sustainability framework here.

We create long-term value through our progress toward these imperatives and sustainability focus areas, which we measure through our corporate philosophy metrics. More details on these metrics, including why they matter, can be found in the Annual Integrated Report.

KPMG AZSA Sustainability Co., Ltd., undertook limited assurance on our corporate philosophy metrics. Assured content can be found below.

Independent assurance report

Highlights from FY2022

Here are some FY2022 achievements taken from our 2023 Annual Integrated Report. Learn more about our efforts and progress in the report.

$4.8 billion in R&D investments

42% women and non-binary representation in senior-most levels of the organization

34% reduction in Scope 1 and Scope 2 GHG emissions (in metric tonnes) compared to FY2016